[{"id":"4ad14ef8-b4e9-4380-9939-f8359daf8bbc","acronym":"HEAD-MET","url":"https://clinicaltrials.gov/study/NCT03510390","created_at":"2021-01-18T17:16:43.390Z","updated_at":"2024-07-02T16:36:20.573Z","phase":"","brief_title":"Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation","source_id_and_acronym":"NCT03510390 - HEAD-MET","lead_sponsor":"University Hospital Inselspital, Berne","biomarkers":" TP53 • VEGFA • HIF1A • HMOX1 • NFKB1 • CA9 • CASP3 • MMP9 • SERPINE1 • PER1 • APEX1 • EGLN1 • EGR1 • HNF1A • PLAU • NCOA1","pipe":"","alterations":" ","tags":["TP53 • VEGFA • HIF1A • HMOX1 • NFKB1 • CA9 • CASP3 • MMP9 • SERPINE1 • PER1 • APEX1 • EGLN1 • EGR1 • HNF1A • PLAU • NCOA1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 06/13/2018","start_date":" 06/13/2018","primary_txt":" Primary completion: 09/15/2021","primary_completion_date":" 09/15/2021","study_txt":" Completion: 11/15/2021","study_completion_date":" 11/15/2021","last_update_posted":"2021-11-18"}]